Authors: BATTIE MM WEINRYB I NEEFE DL KLAMERUS KJ BURGHART PH MAYER PR

Citation: Mm. Battie et al., PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS BETWEEN TASOSARTAN AND ENALAPRIL IN HYPERTENSIVES, Journal of hypertension, 16, 1998, pp. 1547-1547

Authors: BATTLE MM KLAMERUS KJ NEEFE DL GEORGIEFF IS MAYER PR

Citation: Mm. Battle et al., PHARMACOKINETIC AND PHARMACODYNAMIC STUDY OF THE POTENTIAL-DRUG INTERACTION BETWEEN TASOSARTAN AND WARFARIN IN HEALTHY-SUBJECTS, Journal of hypertension, 16, 1998, pp. 1567-1567

Authors: BATTLE MM ABOUGHARBI N KLAMERUS KJ NEEFE DL WEINRYB I BURGHART PH MAYER PR

Citation: Mm. Battle et al., INFLUENCE OF A HIGH-FAT MEAL ON THE BIOAVAILABILITY OF TASOSARTAN, Journal of hypertension, 16, 1998, pp. 31007-31007

Authors: UJHELYI MR KLAMERUS KJ VADIEI K ORANGERS E IZARD M NEEFE DL ZIMMERMAN JJ CHOW MSS

Citation: Mr. Ujhelyi et al., DISPOSITION OF INTRAVENOUS AMIODARONE IN SUBJECTS WITH NORMAL AND IMPAIRED RENAL-FUNCTION, Journal of clinical pharmacology, 36(2), 1996, pp. 122-130

Authors: KLAMERUS KJ VADIEI K BURGHART P NEEFE DL ZIMMERMAN JJ

Citation: Kj. Klamerus et al., ASCENDING, SINGLE-DOSE, SAFETY, TOLERANCE, AND PHARMACOKINETICS (PK) OF ENYL]-4-YL)METHYL]PYRIDO[2,3-D]PYRIMIDIN-7(6H)-ONE (ANA-756), Clinical pharmacology and therapeutics, 57(2), 1995, pp. 203-203

Authors: KORTHBRADLEY JM CEVALLOS WH MCPHERSON MK DECLEENE SA NEEFE DL

Citation: Jm. Korthbradley et al., PK PD EVALUATION OF THE POTENTIAL INTERACTION BETWEEN BROMFENAC AND WARFARIN/, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 124-124